13:18:22 EST Thu 26 Nov 2020
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save

News for C:TRIL from 2019-11-27 to 2020-11-26 - 49 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2020-11-17 11:36C:TRILTrillium Therapeutics Inc (2)19.84SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-11-17 11:36C:TRILTrillium Therapeutics Inc (2)19.84SEDAR MD & ASEDAR MD & A
2020-11-16 08:18C:TRILTrillium Therapeutics Inc (2)19.84News ReleaseTrillium loses $173M (U.S.) in nine months
2020-11-12 16:20C:TRILTrillium Therapeutics Inc (2)18.47News ReleaseTrillium Therapeutics appoints Pucci to board
2020-11-02 16:24C:TRILTrillium Therapeutics Inc (2)16.49News ReleaseTrillium appoints Dr. Bruns as chief medical officer
2020-11-02 16:22C:TRILTrillium Therapeutics Inc (2)16.49News ReleaseTrillium forms scientific advisory board
2020-10-05 08:12C:TRILTrillium Therapeutics Inc (2)19.43News ReleaseTrillium gets USPTO notices of allowance for 2 patents
2020-09-21 09:07C:TRILTrillium Therapeutics Inc (2)20.15In the NewsFP/wire say Fortuna, others added to S&P/TSX Comp
2020-09-18 07:26C:TRILTrillium Therapeutics Inc (2)20.89News ReleaseTrillium appoints Kamarck to board
2020-09-16 16:16C:TRILTrillium Therapeutics Inc (2)19.40News ReleaseTrillium Therapeutics closes offering for $149M (U.S.)
2020-09-14 08:06C:TRILTrillium Therapeutics Inc (2)18.58In the NewsGlobe says Fortuna, others join S&P Composite
2020-09-11 18:34C:TRILTrillium Therapeutics Inc (2)18.58MiscellaneousTrillium Therapeutics added to S&P/TSX Composite
2020-09-11 07:56C:TRILTrillium Therapeutics Inc (2)18.31In the NewsGlobe says Trillium Therapeutics elevated to "buy"
2020-09-10 20:04C:TRILTrillium Therapeutics Inc (2)18.31News ReleaseTrillium Therapeutics prices $130M (U.S.) offering
2020-09-09 16:08C:TRILTrillium Therapeutics Inc (2)17.93News ReleaseTrillium Therapeutics arranges public share offering
2020-09-08 17:12C:TRILTrillium Therapeutics Inc (2)12.52News ReleaseTrillium arranges $25M registered direct offering
2020-09-08 16:18C:TRILTrillium Therapeutics Inc (2)12.52News ReleaseTrillium Therapeutics continues dose escalation studies
2020-08-12 08:28C:TRILTrillium Therapeutics Inc (2)11.08News ReleaseTrillium spends $10.14M (U.S.) on R&D in H2020
2020-08-12 07:40C:TRILTrillium Therapeutics Inc (2)11.08SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-08-12 07:40C:TRILTrillium Therapeutics Inc (2)11.08SEDAR MD & ASEDAR MD & A
2020-07-30 09:45C:TRILTrillium Therapeutics Inc (2)8.89News ReleaseTrillium Therapeutics increases dose for TTI-621 study
2020-07-29 08:50C:TRILTrillium Therapeutics Inc (2)9.72In the NewsGlobe says Sagicor Financial, others may rebound nicely
2020-07-06 09:24C:TRILTrillium Therapeutics Inc (2)10.63News ReleaseTrillium shareholders elect six directors at AGM
2020-05-29 09:56C:TRILTrillium Therapeutics Inc (2)News ReleaseTrillium releases data from phase 1 TTI-662 study
2020-05-15 17:08C:TRILTrillium Therapeutics Inc (2)8.11News ReleaseTrillium Therapeutics spends $4.3M (U.S.) on Q1 R&D
2020-05-15 17:05C:TRILTrillium Therapeutics Inc (2)8.11SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2020-05-15 17:05C:TRILTrillium Therapeutics Inc (2)8.11SEDAR MD & ASEDAR MD & A
2020-05-06 09:19C:TRILTrillium Therapeutics Inc (2)7.45News ReleaseTrillium arranges $50M at-the-market program
2020-04-08 07:33C:TRILTrillium Therapeutics Inc (2)5.90News ReleaseTrillium expects pause or slowdown in patient enrolment
2020-03-20 10:37C:TRILTrillium Therapeutics Inc (2)4.35Resume TradingTrillium Therapeutics to resume at 7:27 a.m. PT
2020-03-20 10:36C:TRILTrillium Therapeutics Inc (2)4.35Halt TradingTrillium Therapeutics halted at 7:22 a.m. PT
2020-03-10 07:16C:TRILTrillium Therapeutics Inc (2)7.68SEDAR Annual Information FormSEDAR Annual Information Form
2020-03-10 07:16C:TRILTrillium Therapeutics Inc (2)7.68SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2020-03-10 07:10C:TRILTrillium Therapeutics Inc (2)7.68SEDAR MD & ASEDAR MD & A
2020-03-10 07:05C:TRILTrillium Therapeutics Inc (2)7.54News ReleaseTrillium spends $27.17M (U.S.) on R&D in 2019
2020-02-28 12:42C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 10 a.m. PT
2020-02-28 12:39C:TRILTrillium Therapeutics Inc (2)4.56News ReleaseTrillium does not say why stock is up
2020-02-28 12:28C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 9:25 a.m. PT
2020-02-28 11:14C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 8:16 a.m. PT
2020-02-28 11:13C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 8:11 a.m. PT
2020-02-28 09:53C:TRILTrillium Therapeutics Inc (2)4.56Halt TradingTrillium Therapeutics halted at 6:50 a.m. PT
2020-02-28 09:52C:TRILTrillium Therapeutics Inc (2)4.56Resume TradingTrillium Therapeutics to resume at 6:55 a.m. PT
2020-02-07 07:50C:TRILTrillium Therapeutics Inc (2)5.00News ReleaseTrillium Therapeutics appoints Walker to board
2020-01-29 07:12C:TRILTrillium Therapeutics Inc (2)5.85News ReleaseTrillium closes $116.95-million (U.S.) financing
2020-01-24 21:15C:TRILTrillium Therapeutics Inc (2)5.90Prospectus ApprovedTrillium to list 35,731,818 more shares Jan. 28
2020-01-23 08:40C:TRILTrillium Therapeutics Inc (2)5.56News ReleaseTrillium prices equity raise at $2.75 (U.S.) a share
2020-01-22 16:18C:TRILTrillium Therapeutics Inc (2)4.28News ReleaseTrillium arranges public offering of shares, preferreds
2020-01-16 09:14C:TRILTrillium Therapeutics Inc (2)3.67News ReleaseTrillium regains compliance with Nasdaq bid price rule
2020-01-07 09:43C:TRILTrillium Therapeutics Inc (2)1.51News ReleaseTrillium increases dosing for TTI-621 program